Corient Private Wealth LLC Has $18.82 Million Position in STERIS plc (NYSE:STE)

Corient Private Wealth LLC lowered its holdings in STERIS plc (NYSE:STE - Free Report) by 9.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,528 shares of the medical equipment provider's stock after selling 9,647 shares during the period. Corient Private Wealth LLC owned approximately 0.09% of STERIS worth $18,815,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Geode Capital Management LLC lifted its holdings in shares of STERIS by 0.7% in the third quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider's stock valued at $556,786,000 after purchasing an additional 17,007 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of STERIS by 0.5% in the fourth quarter. Principal Financial Group Inc. now owns 1,119,643 shares of the medical equipment provider's stock valued at $230,160,000 after purchasing an additional 5,419 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of STERIS in the fourth quarter valued at $223,987,000. Franklin Resources Inc. lifted its holdings in shares of STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after purchasing an additional 529,308 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of STERIS by 3.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider's stock worth $117,136,000 after acquiring an additional 18,384 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of research firms have recently weighed in on STE. JMP Securities reaffirmed a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. Stephens reaffirmed an "overweight" rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler upped their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, STERIS presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

STERIS Stock Down 2.3 %

STERIS stock traded down $5.13 during mid-day trading on Friday, hitting $220.34. 1,348,122 shares of the company's stock were exchanged, compared to its average volume of 504,894. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The stock has a market cap of $21.65 billion, a P/E ratio of 46.78 and a beta of 0.92. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The stock has a 50 day moving average of $221.02 and a two-hundred day moving average of $222.12.

STERIS (NYSE:STE - Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS's payout ratio is 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.